A woman is born with her complete supply of eggs, and no new eggs are made at any point in her life. This supply declines steadily from before birth onward, and the rate of decline speeds up in the mid to late thirties.
At the same time, the proportion of eggs carrying chromosomal abnormalities rises with age. These are two separate processes; they happen at different rates in different women, and together they explain most of what is called age-related decline in fertility. Understanding which parts of this can be changed, and which cannot, is useful for anyone planning a pregnancy after 35 or considering treatment.
Ovarian Aging and Fertility: Two Separate Processes
The relationship between ovarian aging and fertility involves both the number of eggs and their quality, and the two decline independently.
Quantity implies the number of eggs remaining in the ovary, known clinically as the ovarian reserve. It determines how many follicles respond to stimulation in an IVF cycle. It can be measured reasonably well through an AMH blood test and an antral follicle count on ultrasound.
Quality refers to the proportion of eggs capable of producing a chromosomally normal embryo. An egg stays suspended partway through its final division for decades, and the cell structures that hold its chromosomes in place weaken over that time. When the division finishes at ovulation, mistakes in separating the chromosomes become increasingly common with age.
The important point is that no available test measures egg quality directly. A woman with a reassuring AMH result may still have a high proportion of chromosomally abnormal eggs, because AMH shows how many eggs are present, not how well they will perform.
Age-Related Fertility Decline: What Changes
Age-related fertility decline affects several things at once, which is why its overall effect is larger than any single number suggests.
Monthly chance of conception: The chance of conceiving in any given cycle falls, so conception takes longer on average.
Time to conception: Couples who will eventually conceive naturally usually take longer to get there. This is why the recommended waiting period before seeking assessment becomes shorter with age.
Miscarriage rate: The share of pregnancies ending in loss rises with maternal age, mainly because of chromosomal abnormalities in the embryo.
Response to stimulation: A smaller number of eggs is usually collected in an IVF cycle, which means a smaller number of embryos.
Proportion of normal embryos: A smaller share of the embryos created test as chromosomally normal, which affects how many are suitable for transfer.
Male age matters too, though its effect appears later and more gradually. Sperm DNA damage increases with the father’s age, and this is worth testing where the male partner is older.
Pregnancy After 35: The Clinical Picture
Most pregnancies in women over 35 go smoothly and end with a healthy baby. That deserves to be said plainly, because discussions of risk can hide it.
Certain conditions do occur more often, and pregnancy after 35 is therefore monitored more closely.
Gestational diabetes: More common with increasing maternal age. It is managed with monitoring, dietary changes, and medication where needed.
High blood pressure in pregnancy: Including pre-eclampsia, which is why blood pressure checks are more frequent.
Chromosomal conditions in the baby: The likelihood increases with maternal age, and screening tests are offered accordingly.
Miscarriage: More common, largely because of the embryo’s chromosomal status.
Placental problems and preterm birth: Occur somewhat more often, which shapes the schedule of pregnancy check-ups.
Higher chance of cesarean delivery: Related to both maternal age and the conditions above.
The extra monitoring is a precaution, not a sign that something is wrong.
IVF Success After 35: What Treatment Can and Cannot Do
The most important point about IVF success after 35 is understanding what the treatment actually does. IVF collects several eggs in one cycle, fertilizes them under controlled conditions, and allows the best embryo to be selected. It neither improves the quality of eggs collected nor slows ovarian aging.
Success rates using a woman’s own eggs fall with age, and the fall becomes steeper after the late thirties. Two things drive this: a smaller number of eggs is collected, and a smaller share of the embryos created are chromosomally normal. Together, these reduce the chance that any single cycle produces an embryo suitable for transfer.
Several practical points follow.
Results across cycles matter more than a single cycle: The chance of success over several cycles is higher than the figure for one cycle. This is relevant when planning treatment and its cost.
Genetic testing of embryos may be discussed: Testing embryos for chromosomal abnormalities does not increase the number of normal embryos. What it can do is reduce the number of unsuccessful transfers and the time they take. Whether it is worthwhile depends on age, the number of embryos available, and the individual situation.
Donor eggs remain an option: Where egg number or quality is the limiting factor, results with donor eggs depend mainly on the donor’s age. Under the ART Act, egg donors in India must be between 23 and 35 years of age.
Timing is the most influential factor: Because the decline is continuous, time spent deciding usually affects the outcome more than most preparation done during that time.
Fertility After 35 and IVF: When to Seek Assessment
The standard guidance on fertility after 35 and IVF is about when to get evaluated, not when to start treatment.
A woman aged 35 or over is generally advised to seek assessment after six months of trying to conceive, instead of the twelve months advised at younger ages. A woman who is 40 or over, or who has a known factor such as irregular cycles, endometriosis, previous ovarian surgery, or a significant male factor, should not wait even that long.
An initial evaluation is straightforward. It usually includes ovarian reserve testing, an assessment of the uterus and fallopian tubes, thyroid and other hormone tests, and a semen analysis for the male partner. Getting assessed does not commit anyone to treatment, and a normal result is useful information in itself.
Conclusion
Ovarian aging is a biological process that no current treatment reverses. Assisted reproduction works within it, by making the best use of the eggs that remain, not by restoring what has already declined.
That is a real limitation, and it is stated here because realistic expectations lead to better decisions than optimistic ones. It is also not the whole picture. Many women conceive naturally after 35, treatment results remain reasonable through the late thirties for many patients, and where a woman’s own eggs are the limiting factor, other routes to a pregnancy exist.
The factor most within a couple’s control is how soon they seek assessment.
Consult a Fertility Specialist at 9M Fertility
An assessment gives a clear picture of ovarian reserve, the condition of the uterus and tubes, and any contributing male factor. That picture is the basis for deciding whether to keep trying naturally or to consider treatment.
The specialists at 9M Fertility carry out this evaluation for both partners, explain what the results mean at your age, and set out the realistic options along with the expectations attached to each.
Book a consultation with 9M Fertility to discuss your fertility assessment. Contact Us









